Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension von Sharpe, E D, Henry, C J, Mundorf, T K, Day, D G, Stewart, J A, Jenkins, J N, Stewart, W C

Volltext

Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma von Stewart, William C, Dubiner, Harvey B, Mundorf, Thomas K, Laibovitz, Robert A, Sall, Kenneth N, Katz, L.J, Singh, Kuldev, Shulman, David G, Siegel, Les I, Hudgins, Alison C, Nussbaum, Lawrence, Apostolaros, Maria

Volltext

The safety and efficacy of switching timolol maleate 0.5 % solution to timolol hemihydrate 0.5% solution given twice daily von MUNDORF, T. K, CATE, E. A, SINE, C. S, OTERO, D. W, STEWART, J. A, STEWART, W. C

Volltext

Timolol Hemihydrate vs Timolol Maleate to Treat Ocular Hypertension and Open-Angle Glaucoma von DUBINER, HARVEY B., HILL, RICHARD, KAUFMAN, HERBERT, KEATES, EDWIN U., ZIMMERMAN, THOM J., MANDELL, ALAN I., MUNDORF, THOMAS K., BAHR, ROBERT L., SCHWARTZ, LOUIS W., TOWEY, ANNE W., HURVITZ, LAWRENCE M., STARITA, RICHARD J., SASSANI, JOSEPH W., ROPO, AULI, GUNN, RON, STEWART, WILLIAM C.

Volltext

The Spectrum of Cavitary Optic Disc Anomalies in a Family von Slusher, M. Madison, Weaver, R. Grey, Greven, Craig M., Mundorf, Thomas K., Cashwell, L. Frank

Volltext

Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease von Sall, Kenneth, Stevenson, Onex Dara, Mundorf, Thomas K, Reis, Brenda L

Volltext

Automated Perimetry, Tonometry, and Questionnaire in Glaucoma Screening von Mundorf, Thomas K., Zimmerman, Thorn J., Nardin, George F., Kendall, Kenyon S.

Volltext

EFFICACY AND SAFETY OF CYCLOSPORINE OPHTHALMIC EMULSION IN DRY EYE DISEASE von K, Sall, OD, Stevenson, TK, Mundorf

Volltext

Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group von Sall, K, Stevenson, O D, Mundorf, T K, Reis, B L

Volltext

Clinical Success and Quality of Life With Brimonidine 0.2% or Timolol 0.5% Used Twice Daily in Glaucoma or Ocular Hypertension: A Randomized Clinical Trial von Javitt, Jonathan C, Schiffman, Rhett M

Volltext

Timolol LA: a double-masked, active-controlled, randomized, crossover, comfort, ocular safety, and systemic bioavailability study in healthy volunteers von Mundorf, Thomas K., Ogawa, Takahiro, Inui, Noritsugu, Naka, Hiroaki, Novack, Gary D., Stephens Crockett, R.

Volltext

Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study von Khouri, Albert S., Serle, Janet B., Bacharach, Jason, Usner, Dale W., Lewis, Richard A., Braswell, Puiwah, Kopczynski, Casey C., Heah, Theresa, Bacharach, Jason, Benza, Robert, Boyle, John W., Butler, Michelle, Cacioppo, Leonard Robert, Cardona, Jose F., Colborn, Valerie A., Day, Douglas G., Douglass, David T., El-Harazi, Sherif M., Ghate, Deepta, Hartman, Carl, Haverly, Robert F., Katzman, Barry, Kim, Max, Koo, Edward Y., Korenfeld, Michael S., Kwapiszeski, Bradley, Lane, Lydia, Lin, Christopher, Logan, Andrew Gardner, Lozier, Jeffrey Raymond, McQuirter, Henry, Mundorf, Thomas K., Olander, Kenneth, Ou, Richard J., Panzo, Gregory J., Peace, James H., Protzko, Eugene E., Ritch, Robert, Sall, Kenneth, Schechter, Barry A., Seltzer, Samuel Eric, Shah, Pankajkumar G., Sharpe, Elizabeth, Lee Shettle, Philip, Shulman, David G., Singh, Inder Paul, Smith, Stacy R., Smith, Stephen E., Smyth-Medina, Robert John, Sorenson, Robert C., Sturm, Richard, Sulkowski, Gregory M., Sutton, James D., Tepedino, Michael, Tsai, Julie, Tubbs, Carl B., Tukel, David B., Walters, Thomas Richard, Wirta, David L.

Volltext

Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: A phase III, single-center, prospectiv... von Abelson, Mark B., MD, CM, FRCSC, Torkildsen, Gail L., MD, Williams, Jon I., PhD, Gow, James A., BSc (Med), MD, Gomes, Paul J., MS, McNamara, Timothy R., PharmD

Volltext

Multicenter Clinical Evaluation of Bepotastine Besilate Ophthalmic Solutions 1.0% and 1.5% to Treat Allergic Conjunctivitis von Macejko, Thomas T, Bergmann, Mark T, Williams, Jon I, Gow, James A, Gomes, Paul J, McNamara, Timothy R, Abelson, Mark B

Volltext

Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge von Torkildsen, Gail L., MD, Williams, Jon I., PhD, Gow, James A., MD, Gomes, Paul J., MS, Abelson, Mark B., MD, McNamara, Timothy R., PharmD

Volltext

Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis von Meier, Edward J., Torkildsen, Gail L., Gow, James A., McNamara, Timothy R., Gomes, Paul J., Williams, Jon I., for the Bepotastine Besilate Ophthalmic Solutions Study Group

Volltext

The Green Bank North Celestial Cap Survey. VIII. 21 New Pulsar Timing Solutions von Fiore, W., Levin, L., McLaughlin, M. A., Anumarlapudi, A., Kaplan, D. L., Swiggum, J. K., Agazie, G. Y., Bavisotto, R., Chawla, P., DeCesar, M. E., Dolch, T., Fonseca, E., Kaspi, V. M., Komassa, Z., Kondratiev, V. I., van Leeuwen, J., Lewis, E. F., Lynch, R. S., McEwen, A. E., Mundorf, R., Al Noori, H., Parent, E., Pleunis, Z., Ransom, S. M., Siemens, X., Spiewak, R., Stairs, I. H., Surnis, M., Tobin, T. J.

Volltext

A Phase 2 Randomized, Double-Masked, Placebo-Controlled Study of a Novel Integrin Antagonist (SAR 1118) for the Treatment of Dry Eye von Semba, Charles P, Torkildsen, Gail L, Lonsdale, John D, McLaurin, Eugene B, Geffin, Joel A, Mundorf, Thomas K, Kennedy, Kathryn S, Ousler, George W

Volltext

Lithium and glutamine synthetase: Protective effects following stress von Mundorf, Annakarina, Knorr, Alexandra, Mezö, Charlotte, Klein, Christina, Beyer, Dominik KE, Fallgatter, Andreas J, Schwarz, Michael, Freund, Nadja

Volltext

Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-ma... von Day, Douglas G, Walters, Thomas R, Schwartz, Gail F, Mundorf, Thomas K, Liu, Charlie, Schiffman, Rhett M, Bejanian, Marina

Volltext